Quantitation and antigenic characterization of bound C3 of circulating immune complexes in systemic lupus erythematosus, rheumatoid arthritis, and primary biliary cirrhosis
- 1 September 1987
- journal article
- conference paper
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 7 (5) , 420-426
- https://doi.org/10.1007/bf00917020
Abstract
In recent years defective function of the complement-mediated clearance of immune complexes (IC) has been reported in patients with immune complex disease. The defect has been found at different levels in the clearance system. An important event in this sequential system is the binding of C3-coated particles to C3 receptors on erythrocytes and phagocytes. This study focuses on immunochemical properties of IC-bound C3 that reflect the functional state of the molecule. Sera from patients with primary biliary cirrhosis (PBC), rhematoid arthritis (RA), and systemic lupus erythematosus (SLE) and from normal subjects were analyzed for their level of C3 precipitable in 2.7% (w/v) polyethylene glycol (PEG). The mean levels for the patient categories were significantly higher than that for the normal subjects. The immunochemical study revealed several differences among the different forms of PEG-precipitable C3. All forms expressed C3(D) antigens which are expressed by immune complex-associated and denatured forms but not by soluble physiological forms of C3. The expression of these antigens was proportionately lower for the complex-associated C3 of PBC compared to that of RA and SLE. Furthermore, employing monoclonal anti-C3(D) antibodies against the C3c and the C3d domain, distinct differences could be detected among all forms of PEG-precipitable C3. Sera from RA and SLE, in particular, contained PEG-precipitable C3 that exhibited distinctive immunochemical features with respect to these epitopes.Keywords
This publication has 15 references indexed in Scilit:
- Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragmentsMolecular Immunology, 1987
- The Role of Complement and Its Receptor in the Elimination of Immune ComplexesNew England Journal of Medicine, 1986
- SDS denaturation of complement factor C3 as a model for allosteric modifications occurring during C3b binding: demonstration of a profound conformational change by means of circular dichroism and quantitative immunoprecipitationImmunology Letters, 1986
- Identification of a Nonproteolytically Activated C3 with CR 1-Binding Properties in Sera from Subjects with Primary Biliary CirrhosisInternational Archives of Allergy and Immunology, 1986
- An Assessment of the Extent of Antigenic Analogy between Physiologically Bound C3 and C3 Denatured by Sodium Dodecyl SulphateScandinavian Journal of Immunology, 1985
- Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.Journal of Clinical Investigation, 1985
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.The Journal of Experimental Medicine, 1982
- Immune Complex DiseaseVox Sanguinis, 1980
- Maturation of the head of bacteriophage T4Journal of Molecular Biology, 1973